Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-10-009411
Filing Date
2010-11-08
Accepted
2010-11-08 16:24:46
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2199988z10-ka.htm 10-K/A 861349
2 EXHIBIT 23 a2199988zex-23.htm EX-23 3338
3 EXHIBIT 31.1 a2199988zex-31_1.htm EX-31.1 8076
4 EXHIBIT 31.2 a2199988zex-31_2.htm EX-31.2 8102
5 EXHIBIT 32.1 a2199988zex-32_1.htm EX-32.1 4623
6 EXHIBIT 32.2 a2199988zex-32_2.htm EX-32.2 4639
  Complete submission text file 0001047469-10-009411.txt   891773
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-131722 | Film No.: 101172689
SIC: 2834 Pharmaceutical Preparations